Reduction of the fluorine-18-labeled fluorodeoxyglucose dose for clinically dedicated breast positron emission tomography

Reduction of the fluorine-18-labeled fluorodeoxyglucose dose for clinically dedicated breast positron emission tomography

Abstract Purpose To determine the clinically acceptable level of reduction in the injected fluorine-18 (18F)-labeled fluorodeoxyglucose (18F-FDG) dose in dedicated breast positron emission tomography (dbPET). Methods A breast phantom with four spheres exhibiting various diameters (5, 7.5, 10, and 16...

Full description

Bibliographic Details
Main Authors: Yoko Satoh, Tetsuro Sekine, Yoshie Omiya, Hiroshi Onishi, Utaroh Motosugi
Format: Article
Language:English
Published: SpringerOpen 2019-11-01
Series:EJNMMI Physics
Subjects:
Breast cancer
Dedicated breast positron emission tomography
Fluorodeoxyglucose
Dose reduction
Online Access:https://doi.org/10.1186/s40658-019-0256-9

Internet

https://doi.org/10.1186/s40658-019-0256-9

Similar Items